Author:
Kang Su Yun,Amratia Punam,Dunn Julia,Vilay Phoutnalong,Connell Mark,Symons Tasmin,Rumisha Susan,Zhang Song,Ward Abigail,Sichanthongthip Odai,Banouvong Virasack,Shortus Mathew,Reyburn Rita,Butphomvihane Phonephet,Phiphakavong Vilaisak,Hahm Mary,Phongchantha Vilayphone,Khamlome Boualam,Chindavongsa Keobouphaphone,Chanthavisouk Chitsavang,Weiss Daniel J.,Gething Peter W.,Cameron Ewan
Abstract
Abstract
Background
Malaria risk maps are crucial for controlling and eliminating malaria by identifying areas of varying transmission risk. In the Greater Mekong Subregion, these maps guide interventions and resource allocation. This article focuses on analysing changes in malaria transmission and developing fine-scale risk maps using five years of routine surveillance data in Laos (2017–2021). The study employed data from 1160 geolocated health facilities in Laos, along with high-resolution environmental data.
Methods
A Bayesian geostatistical framework incorporating population data and treatment-seeking propensity was developed. The models incorporated static and dynamic factors and accounted for spatial heterogeneity.
Results
Results showed a significant decline in malaria cases in Laos over the five-year period and a shift in transmission patterns. While the north became malaria-free, the south experienced ongoing transmission with sporadic outbreaks.
Conclusion
The risk maps provided insights into changing transmission patterns and supported risk stratification. These risk maps are valuable tools for malaria control in Laos, aiding resource allocation, identifying intervention gaps, and raising public awareness. The study enhances understanding of malaria transmission dynamics and facilitates evidence-based decision-making for targeted interventions in high-risk areas.
Funder
Clinton Health Access Initiative
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. WHO. The Mekong Malaria Elimination Programme. Accelerating malaria elimination in the Greater Mekong, Bulletin 10. Geneva: World Health Organization; 2022. https://www.who.int/publications/i/item/WHO-UCN-GMP-MME-2022.01. Accessed 30 Apr 2024.
2. WHO. Status report on artemisinin and ACT resistance. Geneva: World Health Organization; 2017.
3. Imwong M, Dhorda M, Tun KM, Thu AM, Phyo AP, Proux S, et al. Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study. Lancet Infect Dis. 2020;20(12):1470–80.
4. Souris M, Marcombe S, Laforet J, Brey PT, Corbel V, Overgaard HJ. Modeling spatial variation in risk of presence and insecticide resistance for malaria vectors in Laos. PLoS ONE. 2017;12(5): e0177274.
5. Ong KIC, Khattignavong P, Keomalaphet S, Iwagami M, Brey P, Kano S, et al. Health-seeking behaviours in a malaria endemic district in Lao People’s Democratic Republic: a mixed methods study. BMJ Open. 2021;11(12): e055350.